However, TERT promoter mutations were not associated with gender (OR, 1.17; 95% CI, 0.64–2.15; P= 0.607), tumor size (SMD, 0.14; 95% CI, −0.26 to 0.54; P= 0.503), multifocality (OR, 0.89; 95% CI, 0.19–4.22; P= 0.880), vascular invasion (OR, 2.28; 95% CI, 0.75–6.90; P= 0.144), extrathyroidal extension (OR, 1.57; 95% CI, 0.59–4.15, P= 0.363), and LNM (OR, 1.96; 95% CI, 0.72–5.37; P= 0.190). Here, TERT is linked to neoplasm.